Senior Pharmaceutical Business Development and Portfolio Management Subject Matter Expert

Summary

Join BryceTech as a Subject Matter Expert (SME) supporting the Biomedical Advanced Research and Development Authority (BARDA). You will leverage your extensive pharmaceutical business development and portfolio management expertise to advise on portfolio management decisions, conduct financial analyses, and ensure alignment with BARDA's strategic priorities. Responsibilities include providing expert assessments, reviewing documents, developing work products, and advising federal staff. This role requires at least 17 years of experience in pharmaceutical business development and portfolio management, along with specific experience in evaluating portfolios, conducting business analyses, and financial evaluations of biopharmaceutical assets. The position is likely 100% remote and offers a comprehensive benefits package.

Requirements

• At least 17 years of Pharmaceutical Business Development and Portfolio Management experience
• Industry experience evaluating portfolio strength, conducting business analysis, portfolio rebalancing, and performing financial evaluation of BioPharma assets (e.g., calculations)
• Experience evaluating out‐licensing and in‐licensing Drug Development opportunities
• Experience raising capital (VC, IPO, etc.) to support product development
• Experience providing strategic planning for BioPharma
• Experience managing a diverse portfolio of products and development stages (discovery to commercial) that resembles diversity and scale of BARDA portfolio
• Understanding of MCM design, R&D, licensing, and use required
• Experience with development, implementing, and oversight of pharmaceutical portfolio Total Life Cycle Cost (TLCC)

Responsibilities

• Support BARDA Program Office(s) as a subject matter expert in the fields of Chemical Threats, Radiological/Nuclear Threats, Burn and Blast Injuries, or Biological Threats (including viral and bacterial threats), Influenza and Emerging Infectious Diseases Division (IEIDD) as well as the research, development, manufacture, and regulatory approval/licensure/clearance of medical countermeasures against these threats including but not limited to diagnostics and other medical devices/infrastructure vaccines and other preventives, and therapeutics
• Provide guidance and recommendations on key issues related to the area(s) identified above
• Serve as advisor(s) on Technical Evaluation Panels (TEPs) to include white papers/market research abstracts, technical proposals, and budget proposals
• Participate as subject matter experts on Program Coordination Teams (PCTs)
• Provide expert assessments, recommendations, and guidance as well as educational material to PCT and COR as needed
• Provide subject matter expertise and advisory support to federal staff for development of cost estimates for notional programs/proposed work
• Review and comment on study protocols, study reports, regulatory documents, presentations, proposals, and related documents
• Develop work products (including but not limited to expert summary reports, expert opinion assessment reports, analysis reports, manuscript writing/contribution, and review and technical assessments on a wide variety of documents related to BARDA’s mission, including solicitations, white papers, proposals, and post-award contract documents and deliverables), as requested in their SME area and at their required level of expertise
• Advise federal staff on the appropriateness and the probability of success of Contractor proposed statements of work Make suggestions on ways to improve those statements of work
• Experience distilling complex information into informative and concise summaries, including providing risk/benefit analyses and balanced recommendations
• Participate and aid in strategic discussions, working with USG, in building new program areas in alignment with BARDA’s mission space
• Provide recommendations for project development level portfolio management and oversight as required
• Provide recommendations or advise on development, implement, and consciously improve Total Life Cycle Cost (TLCC) efforts; Participate in Market Research efforts
• Advise the Office of Director on Portfolio Management Decisions
• Provide financial analysis on medical countermeasure products that have both commercial and bio defense indications, specifically identifying the sustainability / viability of a commercial market
• Provide financial analysis to BARDA on the impact of proposed economic incentives
• Support the implementation of enhanced Portfolio Management for BARDA
• Ensure alignment of Division portfolios with BARDA strategic priorities
• Evaluate commercial feasibility of a drug development candidate, feasibility of vendor managed inventory and other alternatives to stockpiling MCMs
• Managing key projects, stakeholders, and personnel, such as biochemical engineers, researchers, scientists, healthcare consultant, and physicians
• Establishing and maintaining timelines for drug trials and ensuring proper, compliant completion of each one
• Staying up to date on all applicable regulatory guidelines, like rules from the U.S. Food and Drug Administration
• Keeping detailed records on the progress of research, trials, and approvals from one phase to the next, in accordance with regulatory mandates and corporate governance rules
• Evaluating the results of trials and in appropriate cases choosing to halt development due to safety concerns, in efficacy or side effects

Preferred Qualifications

Industry experience preferred with alliance / M&A sourcing experience

Benefits

• Competitive salary
• A comprehensive health plan including dental and vision coverage
• Company-paid life & disability insurance policies
• 401(k) plan with company match
• An educational reimbursement program
• This position will most likely be 100% remote